Posted on

TOP 5 HEALTH LAWS AND POLICY UPDATES

Dear Readers, we are happy to share the most interesting legal and policy updates concerning health industry that we read today. We hope you enjoy reading it.

1. India’s central food authority, FSSAI has notified the Food Safety and Standards (Vegan Foods) Amendment Regulations, 2026 which introduces revised official logo specifications for approved vegan food products, replacing the 2022 framework. Mandating the updated logo on all approved packages, the new requirements will take effect from July 1, 2027, offering businesses a transition period for packaging updates.
Source: shortlink.uk/1qVzx

2. The Department of Consumer Affairs has amended the Legal Metrology (Packaged Commodities) Rules, 2011, allowing importers to make mandatory declarations at bonded warehouses of Tier-2 and Tier-3 Authorised Economic Operators. The amendments also require disclosure of the director responsible for violations, mandate annual updates of registration details, and clarify that registration certificates will remain valid until cancelled.
Source: shortlink.uk/1qVzz

3. The Employees’ State Insurance Corporation (ESIC) has launched a centralized online patient feedback system across its hospitals and dispensaries to strengthen patient-centric healthcare delivery and improve service quality. The digital platform enables beneficiaries to submit feedback on various aspects of healthcare services, including medical care, staff behaviour, cleanliness, waiting time, and overall patient experience. The initiative aims to facilitate real-time monitoring of patient satisfaction, enhance accountability, and support timely resolution of grievances.
Source: shortlink.uk/1wkLy

4. The Delhi High Court has allowed pharmaceutical company to continue selling its cancer drug Bevatas, overturning an earlier order. The court ruled that Bevatas and Bevetex are sufficiently distinct in appearance, pronunciation and use, making consumer confusion unlikely and permitting continued sales.
Source: shortlink.uk/1wkLD

5. The National Medical Commission has issued an advisory directing all medical colleges to mandatorily implement safe injection practices, including exclusive use of sterile single-use needles and syringes, strict infection prevention measures, proper biomedical waste disposal, periodic staff training, and prompt reporting of needle-stick injuries to prevent the transmission of blood-borne infections such as HIV, Hepatitis B (HBV), and Hepatitis C (HCV).
Source: shortlink.uk/1wkLF

Posted on

TOP 5 HEALTH LAWS AND POLICY UPDATES

Dear Readers, we are happy to share the most interesting legal and policy updates concerning health industry that we read today. We hope you enjoy reading it.

1. India’s central health ministry has notified the revised fees for testing or analysis for drugs, vaccines, and AYUSH medicines given under Schedules B and B(1) of the Drugs Rules, 1945. The revised fees will be applicable in three months post-publication in official gazette. The fees shall automatically increase by 5% annually. For the tests that are not listed in the Schedule, charges will be determined by the Director or the Government Analyst of the Laboratory or institute. This update will focus on strengthening India’s testing infrastructure while increasing compliance expenses for manufacturers.
Source: shortlink.uk/1qPI3

2. The Delhi High Court dismissed the appeal challenging exclusive rights in the mark“REDDY” for pharmaceutical goods, affirming cancellation of a conflicting registration and restraining its continued use. The ruling reinforces the importance of acquired distinctiveness, market reputation, and consumer protection in trademark enforcement within regulated industries.
Source: shortlink.uk/1weId

3. This official corrigendum by India’s NPPA, dated May 27, 2026, corrects the manufacturer and brand names under serial number 4 of Table-B in its previous Ringer Lactate ceiling price order (S.O. 1584(E)) (p. 2). The manufacturer is now M/s Fresenius Kabi India, with brands ‘Freeflex bags’ and ‘Eurohead bottle’ (p. 2).
Source: shortlink.uk/1qPID

4. National Pharmaceutical Pricing Authority may reportedly refer the methodology for fixing ceiling prices of intravenous (IV) fluids to its Multi-Disciplinary Committee (MDC) of experts after identifying inconsistencies in pricing across formulations and special-feature packaging. The review will improve transparency and consistency in the pricing of IV fluids while addressing concerns over packaging-related pricing variations.
Source: shortlink.uk/1weIH

5. The Food Safety and Standards Authority of India (FSSAI) has sought an explanation from a leading quick commerce platform following a consumer complaint alleging illness after consuming curd purchased through the platform. The regulator has reportedly requested a detailed Action Taken Report (ATR) and sought information regarding food safety compliance, while noting multiple recent complaints relating to allegedly spoiled, unhygienic, or damaged food products sold through the platform’s marketplace sellers. The development underscores increasing regulatory scrutiny of food safety obligations in the e-commerce and quick commerce sector, particularly concerning platform accountability for products sold by third-party sellers.
Source: shortlink.uk/1weIQ

Posted on

TOP 5 HEALTH LAWS AND POLICY UPDATES

Dear Readers, we are happy to share the most interesting legal and policy updates concerning health industry that we read today. We hope you enjoy reading it.

1. The Bombay High Court granted an ad-interim injunction in favour of major drug manufacturer in a trademark dispute involving the marks “ASCORIL” and “ASCOTRAL.” The Court found the marks are visually and phonetically similar and likely to confuse consumers. The confusion in medicinal products could have serious health consequences. The Court restrained the defendant from using the mark.
Source: shortlink.uk/1pUOw

2. The Delhi High Court granted summary judgment in a trademark infringement suit involving protein supplement products, holding that the impugned marks ‘PROTEX’ and ‘PROTRILEX’ were deceptively similar to a long-standing registered mark. Observing structural, visual, and phonetic similarity, the Court permanently restrained use of the impugned marks and reiterated strong judicial protection for established healthcare and nutrition brands.
Source: shortlink.uk/1pUOD

3. Indian Pharmacopoeia Commission has reportedly signed memoranda of understanding with the Bihar, Maharashtra and Mizoram State Pharmacy Councils to strengthen pharmacovigilance, promote rational use of medicines, and enhance patient safety initiatives across states. The initiative focuses on wider adoption of the National Formulary of India (NFI), strengthening adverse drug reaction (ADR) reporting under the Pharmacovigilance Programme of India (PvPI), establishing ADR Monitoring Centres, and conducting pharmacist training and awareness programmes.
Source: shortlink.uk/1vgVQ

4. Delhi High Court, while deciding a trademark infringement case involving CALPOL and WALPOL, declared CALPOL, a well-known trademark in relation to medicinal and pharmaceutical product under the Trade Marks Act, 1999 citing its decades-long use, strong consumer recognition, and extensive nationwide sales. The Court held that WALPOL was deceptively similar and capable of misleading consumers in the pharmaceutical market.
Source: shortlink.uk/1vgVT

5. Narcotics Control Bureau (NCB) has seized a large consignment of Captagon tablets and powder, a banned psychotropic stimulant, under Operation RAGEPILL and arrested a foreign national allegedly linked to an international drug trafficking syndicate. The operation marks India’s first Captagon seizure and underscores intensified enforcement against transnational synthetic drug trafficking networks.
Source: shortlink.uk/1pUOR

Posted on

TOP 5 HEALTH LAWS AND POLICY UPDATES

Dear Readers, we are happy to share the most interesting legal and policy updates concerning health industry that we read today. We hope you enjoy reading it.

1. The Government of India is considering capping billing margins charged by private hospitals on medical devices to curb overcharging and reduce treatment costs. This is important as excessive markups increase patient expenses and insurance premiums. If implemented, it will limit hospital margins, improving pricing transparency and affordability.
Source: shortlink.uk/1olUB

2. The Central Government has established the Online Gaming Authority of India (OGAI), with effect from May 1, 2026, under the Promotion and Regulation of Online Gaming Act, 2025, to regulate the gaming sector. Operating under MeitY, this multi-sectoral authority will oversee licensing, mandate registration for esports, and enforce stringent compliance requirements, with a view to enhancing user safety and strengthening regulatory oversight of online gaming.
Source: shortlink.uk/1tDQe

3. Indias central drug ministry has proposed amendment to Drugs Rules 1945 by expanding the list of licences that may be exempted from requiring a Form 29 licence for manufacturing of drugs for test or analysis. The amendment proposes to include Forms 25A (loan licences), 25F (Schedule X drugs), 28A/28B (Schedule C, C(1), and X drugs), 28D/28DA (vaccines, sera, r-DNA drugs), and 28F (umbilical cord blood stem cells). Objections and suggestions from the industry will be considered for thirty days.
Source: shortlink.uk/1tDQk

4. The Delhi High Court has restrained the use of the trademark “MARQ,” finding it deceptively similar to “MARC” and likely to confuse consumers. This reinforces trademark protection by emphasizing that minor spelling differences, use of house marks, or later registrations do not override prior rights and established goodwill.
Source: shortlink.uk/1tDQs

5. Government of India plans a Health Claims Index to transparency and standardize pricing in India health insurance sector. Using anonymized data from the National Health Claims Exchange, it will benchmark claims timelines, approvals and costs, enabling underwriting, reducing inefficiencies, and supporting informed consumer decisions, subject to scale and execution.
Source: shortlink.uk/1olUW